Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen
ASSAY and Drug Development Technologies · 2023
DOI: 10.1089/adt.2022.116 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2023. Verfasst von Aaron M Bender und 5 weiteren Autor:innen. Beteiligte Einrichtung: Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Franklin, Tennessee, USA. Hauptthemen laut MEDLINE: Serotonin, Receptor, Serotonin, 5-HT2B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Antagonists of the serotonin receptor 2B (5-HT2B) have shown great promise as therapeutics for the treatment of pulmonary arterial hypertension, valvular heart disease, and related cardiopathies. Herein, we describe a high-throughput screen campaign that led to the identification of highly potent and selective 5-HT2B antagonists. Furthermore, selected compounds were profiled for their predicted ability to cross the blood-brain barrier. Two exemplary compounds, VU0530244 and VU0631019, were predicted to have very limited potential for brain penetration in human subjects, a critical profile for the development of 5-HT2B antagonists devoid of centrally-mediated adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Franklin, Tennessee, USA.
- Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, USA.
- Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, USA.
- Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
- Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
ORCID-Profile: Aaron M Bender
Förderung
- NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Bender, A. M., Valentine, M. S., Bauer, J. A., Days, E., Lindsley, C. W., & Merryman, W. D. (2023). Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2022.116
Vancouver
Bender AM, Valentine MS, Bauer JA, Days E, Lindsley CW, Merryman WD. Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen. ASSAY and Drug Development Technologies. 2023. doi:10.1089/adt.2022.116
BibTeX
@article{Bender2023,
author = {Bender, Aaron M and Valentine, Michael S and Bauer, Joshua A and Days, Emily and Lindsley, Craig W and Merryman, W David},
title = {Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B Antagonists from a High-Throughput Screen},
journal = {ASSAY and Drug Development Technologies},
year = {2023},
doi = {10.1089/adt.2022.116}
}
EUVIMED